BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4511450)

  • 1. Agglutinating and cytotoxic properties of anti-leukemic sera specific against human leukemic cells, produced in rabbits.
    Sahasrabudhe MB; Prema S; Madyastha KR; Gollerkeri MP
    Indian J Cancer; 1972 Sep; 9(3):189-98. PubMed ID: 4511450
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the use of chemically tagged normal white blood cells as antigens for producing specific immune response against human leukemic cells.
    Sahasrabudhe MB; Prema S; Madyastha KR; Gollerkeri MP
    Indian J Cancer; 1972 Jun; 9(2):101-11. PubMed ID: 4629010
    [No Abstract]   [Full Text] [Related]  

  • 3. Human leukemia antigen. I. Production and characterization of antisera.
    Billing R; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163
    [No Abstract]   [Full Text] [Related]  

  • 4. Human leukemia cell antigens: serologic characterization with xenoantisera.
    Mohanakumar T; Metzgar RS; Miller DS
    J Natl Cancer Inst; 1974 May; 52(5):1435-44. PubMed ID: 4208711
    [No Abstract]   [Full Text] [Related]  

  • 5. [Investigations on the antigenic specificity of leukocytes in acute or chronic leukemias].
    Berceanu S; Stoichita M; Gheorghiu-Teican M; Iamandi I
    Bibl Haematol; 1965; 23():185-91. PubMed ID: 5220456
    [No Abstract]   [Full Text] [Related]  

  • 6. Monospecific antigranulocyte sera against human neutrophils, eosinophils, basophils, and myeloblasts.
    Mahmoud AA; Kellermeyer RW; Warren KS
    Lancet; 1974 Nov; 2(7890):1163-6. PubMed ID: 4139589
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary studies on antigenicity of chronic lymphatic leukemia cells in humans.
    Harlozińska A; Kotlarek-Haus S; Richter R; Brodzka W
    Arch Immunol Ther Exp (Warsz); 1973; 21(3):403-15. PubMed ID: 4125923
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased sensitivity of human leukemic granulocytes to heterophil antibody in normal rabbit sera.
    Bases R; Mendez F; Clark J; Rosenberg A; Milstein D
    J Natl Cancer Inst; 1970 May; 44(5):993-1000. PubMed ID: 5285265
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxic antibody reactive with cultures of lymphoid cells: occurrence in disease and normal human sera.
    Herberman RB; Nam JM
    J Natl Cancer Inst; 1971 Aug; 47(2):489-94. PubMed ID: 5283788
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon.
    Mahmoud AA; Kellermeyer RW; Warren KS
    N Engl J Med; 1974 Feb; 290(8):417-20. PubMed ID: 4521112
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums.
    Metzgar RS; Mohanakumar T; Miller DS
    Science; 1972 Dec; 178(4064):986-8. PubMed ID: 4628523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of antisera to a myelogenous leukemia cell line with the Philadelphia chromosome.
    Whitson ME; Lozzio CB; Lozzio BB; Wust CJ; Sonoda T; Avery B
    J Natl Cancer Inst; 1976 May; 56(5):903-7. PubMed ID: 1069137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic cross-reactivity between human leukemic cells and dinitrophenylated normal leukocytes.
    Madyastha PR; Madyastha KR; Barth RF
    Exp Hematol; 1983 May; 11(5):371-81. PubMed ID: 6406255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological cross-reactivity of anti-sera raised with fluoro dinitro benzene tagged normal human leukocytes against human leukaemic cells.
    Prema S; Madyastha KR; Sahasrabudhe MB
    Indian J Cancer; 1978 Mar; 15(1):53-7. PubMed ID: 680783
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies against human leukemia cell lines.
    Tanigaki N; Yagi Y; Moore GE; Pressman D
    J Immunol; 1967 Feb; 98(2):281-92. PubMed ID: 4163836
    [No Abstract]   [Full Text] [Related]  

  • 16. Human granulocyte-specific nuclear antigen(s). II. Detection of antigens in human proliferative syndromes.
    Briggs RC; Forbes JT; Hnilica LS; Montiel MM; Thor DE
    J Immunol; 1980 Jan; 124(1):243-9. PubMed ID: 6153097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existence of agglutinating and cytotoxic factor on cultured cells in sera.
    Kawaguchi T
    Wakayama Med Rep; 1970 Apr; 14(1):1-10. PubMed ID: 5509590
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibody-dependent cellular cytotoxicity (AAZZ) against leukemia cells--K-cell activity of human leukocytes].
    Thränhardt H; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):824-40. PubMed ID: 6162750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thomsen's antigen in the leukocytes of leukemia patients].
    Berdinskikh MS; Pavliuchenkova RP; Kiseleva AS; Zotikov EA; Kosiakov PN
    Biull Eksp Biol Med; 1987 Mar; 103(3):334-6. PubMed ID: 3470053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the mixed leucocyte reaction by target cell death: a study of leukaemic cells.
    Pegrum GD; Evans CA; Middleton VL; Balfour IC
    Clin Exp Immunol; 1972 Feb; 10(2):251-6. PubMed ID: 4505586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.